A developmental switch between fetal and adult B lymphopoiesis

Annals of the New York Academy of Sciences

Volumn 1362, Issue 1, 2015, Pages 8-15

  Li, Yue Sheng ^a   Zhou, Yan ^a   Tang, Lingjuan ^a   Shinton, Susan A ^a   Hayakawa, Kyoko ^a   Hardy, Richard R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Adult development; B1a B cell; Cord blood; Fetal development; Hematopoietic stem cells

Indexed keywords

MESSENGER RNA; MICRORNA; PEPTIDES AND PROTEINS; PROTEIN LET 7; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ARID3A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; B LYMPHOPOIESIS; FETUS; GENE EXPRESSION; HUMAN; LYMPHOPOIESIS; NONHUMAN; UMBILICAL CORD BLOOD; CYTOLOGY; PHYSIOLOGY;

ADULT; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; FETUS; HUMANS; LYMPHOPOIESIS;

EID: 84959458695     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12769     Document Type: Article

References (53)

1. Hayakawa, K. et al. 1983. The "Ly-1 B" cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
2. Hayakawa, K. et al. 1984. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. U.S.A. 81: 2494-2498.
3. Hayakawa, K. et al. 1985. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161: 1554-1568.
4. Hayakawa, K. et al. 1986. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16: 1313-1316.
5. + B cells: the Ly-1 B lineage? Annu. Rev. Immunol. 6: 197-218.
6. Hardy, R.R. et al. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173: 1213-1225.
7. Hardy, R.R. & K. Hayakawa. 1991. A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. U. S. A. 88: 11550-11554.
8. Zanjani, E.D. et al. 1982. Adult haematopoietic cells transplanted to sheep fetuses continue to produce adult globins. Nature 295: 244-246.
9. Papayannopoulou, T. et al. 1986. Fetal to adult hemopoietic cell transplantation in humans: insights into hemoglobin switching. Blood 67: 99-104.
10. Enver, T. et al. 1990. Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice. Nature 344: 309-313.
11. Jojic, V. et al. 2013. Identification of transcriptional regulators in the mouse immune system. Nat. Immunol. 14: 633-643.
12. Desiderio, S.V. et al. 1984. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311: 752-755.
13. Landau, N.R. et al. 1987. Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol. Cell. Biol. 7: 3237-3243.
14. Xu, J.L. & M.M. Davis. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13: 37-45.
15. Feeney, A.J. 1992. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. J. Immunol. 149: 222-229.
16. Gilfillan, S. et al. 1993. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 261: 1175-1178.
17. Hardy, R.R. et al. 1989. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J. Immunol. 142: 3643-3651.
18. Carmack, C.E. et al. 1990. Rearrangement and selection of VH11 in the Ly-1 B cell lineage. J. Exp. Med. 172: 371-374.
19. Cunningham, A.J. 1974. Large numbers of cells in normal mice produce antibody components of isologous erythrocytes. Nature 252: 749-751.
20. Steele, E.J. & A.J. Cunningham. 1978. High proportion of Ig-producing cells making autoantibody in normal mice. Nature 274: 483-484.
21. Wasserman, R. et al. 1998. A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly. J. Exp. Med. 187: 259-264.
22. Vettermann, C., K. Herrmann & H.M. Jack. 2006. Powered by pairing: the surrogate light chain amplifies immunoglobulin heavy chain signaling and pre-selects the antibody repertoire. Semin. Immunol. 18: 44-55.
23. Melchers, F. et al. 2000. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol. Rev. 175: 33-46.
24. Schatz, D.G. & D. Baltimore. 1988. Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts. Cell 53: 107-115.
25. Oettinger, M.A. et al. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248: 1517-1523.
26. + B cells. Immunol. Rev. 197: 60-74.
27. Wang, H. & S.H. Clarke. 2004. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol. Rev. 197: 51-59.
28. Hayakawa, K. et al. 1999. Positive selection of natural autoreactive B cells. Science 285: 113-116.
29. Wen, L. et al. 2005. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 23: 297-308.
30. Hayakawa, K. et al. 2003. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197: 87-99.
31. Li, Q.J. et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
32. Mayr, F. et al. 2012. The Lin28 cold-shock domain remodels pre-let-7 microRNA. Nucleic Acids Res. 40: 7492-7506.
33. Yuan, J. et al. 2012. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335: 1195-1200.
34. Ikuta, K. et al. 1990. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62: 863-874.
35. Herrscher, R.F. et al. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Develop. 9: 3067-3082.
36. Webb, C.F. et al. 1998. Expression of bright at two distinct stages of B lymphocyte development. J. Immunol. 160: 4747-4754.
37. Webb, C.F. et al. 2000. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165: 6956-6965.
38. Schmidt, C. et al. 2009. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright. EMBO J. 28: 711-724.
39. Zhou, Y. et al. 2015. Lin28b promotes fetal B lymphopoiesis through the transcription factor Arid3a. J. Exp. Med. 212: 569-580.
40. + B cells. Science 236: 81-83.
41. McWilliams, L. et al. 2013. The human fetal lymphocyte lineage: identification by CD27 and LIN28B expression in B cell progenitors. J. Leukoc. Biol. 94: 991-1001.
42. Stall, A.M. et al. 1988. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc. Natl. Acad. Sci. U.S.A. 85: 7312-7316.
43. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17: 521-528.
44. Forster, I., H. Gu & K. Rajewsky. 1988. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J. 7: 3693-3703.
45. Bichi, R. et al. 2002. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl. Acad. Sci. U.S.A. 99: 6955-6960.
46. Rawstron, A.C. et al. 2008. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N. Engl. J. Med. 359: 575-583.
47. Fazi, C. et al. 2011. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood 118: 6618-6625.
48. Widhopf, G.F., 2nd et al. 2004. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104: 2499-2504.
49. Klein, U. & R. Dalla-Favera. 2010. New insights into the pathogenesis of chronic lymphocytic leukemia. Semin. Cancer Biol. 20: 377-383.
50. Catera, R. et al. 2008. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol. Med. 14: 665-674.
51. Chu, C.C. et al. 2010. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 115: 3907-3915.
52. Messmer, B.T. et al. 2004. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200: 519-525.
53. Duhren-von Minden, M. et al. 2012. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489: 309-312.